163 related articles for article (PubMed ID: 35394170)
1. Time course of lesion-induced atrophy in multiple sclerosis.
Carolus K; Fuchs TA; Bergsland N; Ramasamy D; Tran H; Uher T; Horakova D; Vaneckova M; Havrdova E; Benedict RHB; Zivadinov R; Dwyer MG
J Neurol; 2022 Aug; 269(8):4478-4487. PubMed ID: 35394170
[TBL] [Abstract][Full Text] [Related]
2. Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study.
Fuchs TA; Carolus K; Benedict RHB; Bergsland N; Ramasamy D; Jakimovski D; Weinstock-Guttman B; Kuceyeski A; Zivadinov R; Dwyer MG
AJNR Am J Neuroradiol; 2018 Aug; 39(8):1480-1486. PubMed ID: 29976833
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes of deep gray matter shape in multiple sclerosis.
Tsagkas C; Geiter E; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Granziera C; Mallar Chakravarty M; Magon S
Neuroimage Clin; 2022; 35():103137. PubMed ID: 36002960
[TBL] [Abstract][Full Text] [Related]
4. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
Gaetano L; Häring DA; Radue EW; Mueller-Lenke N; Thakur A; Tomic D; Kappos L; Sprenger T
Neurology; 2018 Apr; 90(15):e1324-e1332. PubMed ID: 29540589
[TBL] [Abstract][Full Text] [Related]
5. Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures.
Fuchs TA; Vaughn CB; Benedict RHB; Weinstock-Guttman B; Choudhery S; Carolus K; Rooney P; Ashton K; P Ramasamy D; Jakimovski D; Zivadinov R; Dwyer MG
Mult Scler Relat Disord; 2019 Jan; 27():298-304. PubMed ID: 30453198
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
[TBL] [Abstract][Full Text] [Related]
7. New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis.
Sinnecker T; Ruberte E; Schädelin S; Canova V; Amann M; Naegelin Y; Penner IK; Müller J; Kuhle J; Décard B; Derfuss T; Kappos L; Granziera C; Wuerfel J; Magon S; Yaldizli Ö
J Neurol; 2020 Jan; 267(1):192-202. PubMed ID: 31612322
[TBL] [Abstract][Full Text] [Related]
8. Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.
Sotirchos ES; Gonzalez-Caldito N; Dewey BE; Fitzgerald KC; Glaister J; Filippatou A; Ogbuokiri E; Feldman S; Kwakyi O; Risher H; Crainiceanu C; Pham DL; Van Zijl PC; Mowry EM; Reich DS; Prince JL; Calabresi PA; Saidha S
Mult Scler; 2020 Mar; 26(3):312-321. PubMed ID: 30741108
[TBL] [Abstract][Full Text] [Related]
9. Enlarged choroid plexus in multiple sclerosis is associated with increased lesion load and atrophy in white matter but not gray matter atrophy.
Akaishi T; Fujimori J; Nakashima I
Mult Scler Relat Disord; 2024 Feb; 82():105424. PubMed ID: 38181695
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
Kalinin I; Makshakov G; Evdoshenko E
AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
[TBL] [Abstract][Full Text] [Related]
11. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy.
Engl C; Tiemann L; Grahl S; Bussas M; Schmidt P; Pongratz V; Berthele A; Beer A; Gaser C; Kirschke JS; Zimmer C; Hemmer B; Mühlau M
J Neurol; 2020 Aug; 267(8):2307-2318. PubMed ID: 32328718
[TBL] [Abstract][Full Text] [Related]
13. Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
Koskimäki F; Bernard J; Yong J; Arndt N; Carroll T; Lee SK; Reder AT; Javed A
PLoS One; 2018; 13(12):e0209326. PubMed ID: 30576361
[TBL] [Abstract][Full Text] [Related]
14. Gray matter atrophy cannot be fully explained by white matter damage in patients with MS.
Zhang J; Giorgio A; Vinciguerra C; Stromillo ML; Battaglini M; Mortilla M; Tappa Brocci R; Portaccio E; Amato MP; De Stefano N
Mult Scler; 2021 Jan; 27(1):39-51. PubMed ID: 31976807
[TBL] [Abstract][Full Text] [Related]
15. Gray matter atrophy in relapsing-remitting multiple sclerosis is associated with white matter lesions in connecting fibers.
Bussas M; Grahl S; Pongratz V; Berthele A; Gasperi C; Andlauer T; Gaser C; Kirschke JS; Wiestler B; Zimmer C; Hemmer B; Mühlau M
Mult Scler; 2022 May; 28(6):900-909. PubMed ID: 34591698
[TBL] [Abstract][Full Text] [Related]
16. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
Kim G; Chu R; Yousuf F; Tauhid S; Stazzone L; Houtchens MK; Stankiewicz JM; Severson C; Kimbrough D; Quintana FJ; Chitnis T; Weiner HL; Healy BC; Bakshi R
Int J Neurosci; 2017 Nov; 127(11):971-980. PubMed ID: 28100092
[TBL] [Abstract][Full Text] [Related]
17. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.
Preziosa P; Pagani E; Mesaros S; Riccitelli GC; Dackovic J; Drulovic J; Filippi M; Rocca MA
Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103
[TBL] [Abstract][Full Text] [Related]
18. Grey matter atrophy in patients with benign multiple sclerosis.
Niiranen M; Koikkalainen J; Lötjönen J; Selander T; Cajanus A; Hartikainen P; Simula S; Vanninen R; Remes AM
Brain Behav; 2022 Jul; 12(7):e2679. PubMed ID: 35765699
[TBL] [Abstract][Full Text] [Related]
19. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
[TBL] [Abstract][Full Text] [Related]
20. The Impact of MRI T1 Hypointense Brain Lesions on Cerebral Deep Gray Matter Volume Measures in Multiple Sclerosis.
Buyukturkoglu K; Mormina E; De Jager PL; Riley CS; Leavitt VM
J Neuroimaging; 2019 Jul; 29(4):458-462. PubMed ID: 30892794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
